Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Sangamo Therapeutics Ownership Summary

Sangamo Therapeutics is owned by 5.12% institutional investors, 2.08% insiders, and 92.80% retail investors. Vanguard group is the largest institutional shareholder, holding 3.94% of SGMO shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.51% of its assets in Sangamo Therapeutics shares.

SGMO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Sangamo Therapeutics	5.12%	2.08%	92.80%
Sector	Healthcare Stocks	232.51%	10.72%	-143.23%
Industry	Biotech Stocks	384.56%	10.58%	-295.14%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	12.00M	3.94%	$5.04M
Renaissance	8.43M	2.77%	$3.54M
Blackrock	4.70M	2.61%	$1.69M
Jacobs levy equity management	2.95M	1.64%	$1.06M
Blackrock funding, inc. /de	4.57M	1.50%	$1.92M
Millennium management	2.74M	1.31%	$2.79M
Geode capital management	3.87M	1.27%	$1.62M
Two sigma investments, lp	2.48M	0.96%	$1.67M
Jane street group	2.92M	0.96%	$1.23M
Two sigma advisers, lp	2.11M	0.82%	$1.42M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Luminus management	250.00K	0.15%	$168.35K
Diametric capital, lp	359.01K	0.09%	$241.75K
Ikarian capital	1.29M	0.09%	$871.82K
Wealth management associates	315.80K	0.05%	$132.64K
Hedges asset management	125.00K	0.04%	$52.50K
R squared	147.19K	0.03%	$61.82K
Golden state equity partners	395.94K	0.03%	$166.30K
Two sigma securities	65.31K	0.01%	$43.98K
Meritage portfolio management	227.00K	0.01%	$95.34K
Renaissance	8.43M	0.01%	$3.54M

Top Buyers

Holder	Shares	% Assets	Change
Jacobs levy equity management	2.95M	0.00%	2.76M
Two sigma investments, lp	2.48M	0.00%	1.60M
Two sigma advisers, lp	2.11M	0.00%	901.62K
Millennium management	2.74M	0.00%	828.34K
Jane street group	2.92M	0.00%	717.44K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-14.06M
Blackrock	4.70M	-	-8.57M
Acadian asset management	-	-	-4.56M
Gsa capital partners llp	78.15K	0.00%	-3.58M
Point72 asset management	-	-	-2.00M

New Positions

Holder	Shares	% Assets	Change	Value
Diametric capital, lp	359.01K	0.09%	359.01K	$241.75K
Luminus management	250.00K	0.15%	250.00K	$168.35K
Hedges asset management	125.00K	0.04%	125.00K	$52.50K
State of wyoming	111.53K	0.01%	111.53K	$46.84K
Two sigma securities	65.31K	0.01%	65.31K	$43.98K

Sold Out

Holder	Change
Barclays	-1.00
Headlands	-5.00
Srs capital advisors	-31.00
Td waterhouse canada	-31.00
Gps wealth strategies group	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	37	-68.91%	15,567,844	-75.13%	5	0.86%	15	-72.73%	8	-60.00%
Sep 30, 2025	43	-61.95%	19,880,715	-60.46%	7	2.02%	17	-63.83%	7	-75.86%
Jun 30, 2025	118	-9.92%	51,227,326	-2.55%	19	3.50%	47	-16.07%	32	-5.88%
Mar 31, 2025	130	-4.41%	52,338,132	-14.91%	23	2.73%	55	-22.54%	34	9.68%
Dec 31, 2024	132	18.92%	56,338,818	0.73%	27	3.75%	67	63.41%	31	-6.06%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	5.65M	2.51%	1.00
Wasatch Ultra Growth	5.59M	2.28%	1.06M
Vanguard Total Stock Mkt Idx Inv	5.86M	2.15%	-129.35K
SPDR® S&P Biotech ETF	3.73M	1.75%	-22.75K
Wasatch Micro Cap	2.34M	1.12%	-3.31M
Vanguard Institutional Extnd Mkt Idx Tr	2.36M	0.87%	-709.77K
Vanguard Strategic Small-Cap Equity Inv	1.71M	0.82%	-
Vanguard Explorer Inv	1.40M	0.67%	-
Fidelity Extended Market Index	1.16M	0.38%	113.75K
Schwab US Small-Cap ETF™	1.07M	0.36%	2.73K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 26, 2023	BIOGEN INC.	-	Sell	$3.00M
Aug 29, 2022	BIOGEN INC.	-	Sell	$2.13M
Aug 30, 2022	BIOGEN INC.	-	Sell	$526.52K
Aug 29, 2022	Biogen MA Inc.		Sell	$526.52K
Aug 29, 2022	Biogen MA Inc.		Sell	$2.13M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	-
2025 Q3	-	-
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

SGMO Ownership FAQ

Who Owns Sangamo Therapeutics?

Sangamo Therapeutics shareholders are primarily institutional investors at 5.12%, followed by 2.08% insiders and 92.80% retail investors. The average institutional ownership in Sangamo Therapeutics's industry, Biotech Stocks , is 384.56%, which Sangamo Therapeutics falls below.

Who owns the most shares of Sangamo Therapeutics?

Sangamo Therapeutics’s largest shareholders are Vanguard group (12M shares, 3.94%), Renaissance (8.43M shares, 2.77%), and Blackrock (4.7M shares, 2.61%). Together, they hold 9.32% of Sangamo Therapeutics’s total shares outstanding.

Does Blackrock own Sangamo Therapeutics?

Yes, BlackRock owns 2.61% of Sangamo Therapeutics, totaling 4.7M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.69M$. In the last quarter, BlackRock decreased its holdings by -8.575M shares, a -64.58% change.

Who is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested?

Luminus management is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.15% of its assets in 250K Sangamo Therapeutics shares, valued at 168.35K$.

Who is the top mutual fund holder of Sangamo Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Sangamo Therapeutics shares, with 2.51% of its total shares outstanding invested in 5.65M Sangamo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools